VFP-B-3

N/A

Report date: 2025/01/26 15:40:50
NME

Base Information

Drug NameVFP-B-3
Drug Alias Namedual PDE4/PDE7 inhibitors (Palacky University)VFP-B-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitorsPhosphodiesterase 7 inhibitors
TargetsPhosphodieterase 4Phosphodiesterase 7
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPalacky University
China Registration ClassN/A

Develop Information

Active CompaniesPalacky University
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A